Global consumer healthcare company Haleon has announced plans to establish a new manufacturing facility in Madhya Pradesh with an investment of approximately ₹2,000 crore, marking one of the largest investments in India’s consumer healthcare manufacturing sector in recent years.

The proposed facility is expected to strengthen Haleon’s manufacturing capabilities in India while supporting the growing demand for consumer health products across domestic and international markets. The investment aligns with India’s vision of becoming a global manufacturing hub and further reinforces Madhya Pradesh’s position as an emerging destination for healthcare and pharmaceutical investments.

Industry experts believe the project will generate significant employment opportunities, strengthen local supply chains, and contribute to economic development in the region. Large-scale healthcare manufacturing investments also play a crucial role in enhancing production capacity, improving product availability, and supporting export growth.

Haleon, a global leader in consumer health, operates a portfolio of well-known brands across oral health, pain relief, respiratory health, digestive wellness, and nutritional products. The company’s expansion in India reflects the country’s growing importance as a strategic market for healthcare and wellness products.

India’s consumer healthcare sector continues to witness strong growth driven by increasing health awareness, rising disposable incomes, expanding retail networks, and growing demand for preventive healthcare products. Industry estimates suggest that the Indian consumer health market is expected to maintain robust growth over the coming decade, supported by urbanization and increasing healthcare expenditure.

The proposed manufacturing unit is expected to incorporate advanced production technologies, quality systems, and sustainable manufacturing practices. Experts note that investments in modern healthcare manufacturing facilities can improve operational efficiency, product quality, and supply chain resilience while supporting the country’s “Make in India” initiative.

State government officials have welcomed the investment, highlighting its potential to attract additional healthcare and pharmaceutical companies to the region. Large scale industrial projects often serve as catalysts for broader economic development, infrastructure improvement, and workforce skill enhancement.

Healthcare industry analysts believe India’s growing manufacturing ecosystem, supportive policy environment, and expanding domestic market continue to attract global healthcare companies seeking long term growth opportunities.

The ₹2,000-crore investment underscores increasing confidence in India’s healthcare manufacturing sector and reflects the country’s expanding role in global healthcare supply chains. Once operational, the facility is expected to contribute significantly to Haleon’s regional growth strategy while strengthening India’s position as a key production and innovation hub for consumer healthcare products.